课题基金 / 基金详情

Role of Linker Histone H1 Variants in Cardiac Phenotype in Health and Disease

Role of Linker Histone H1 Variants in Cardiac Phenotype in Health and Disease
连接组蛋白 H1 变异体在健康和疾病中心脏表型中的作用
批准号:
8325241
负责人:
Michelle Parvatiyar
金额:
$5.22万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-08-01 至 2013-07-31

项目摘要

项目成果

Michelle Parvatiyar的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):成人心脏是一个动态器官;然而,心肌细胞在出生后不久就会分化为终末细胞。随着时间的推移,成年心肌细胞暴露在多种病理应激源下,可导致肥大生长和功能障碍。疾病的发展导致各种适应性反应,包括胎儿蛋白的重新表达。尽管控制肥厚的途径的知识取得了进展,但人们对基因调节的修饰物如何影响心脏的解剖重新编程知之甚少。我推测,组蛋白变体是控制疾病心脏和衰竭心脏基因表达变化的重要调节器。为了研究心脏疾病发展过程中染色质结合蛋白的变化,我们通过缩窄小鼠的横主动脉来诱导心肌肥厚。我们实验室的蛋白质组学分析从心脏细胞核中鉴定出1048种蛋白质,其中包括54种组蛋白变体,并揭示了核小体化学计量学的明显变化,这些变化与心脏疾病在器官水平的表现有关。此外,对个别组蛋白H1变异体--所谓的连接器组蛋白,负责形成高阶染色质结构--的分析显示,在心肌肥厚期间表达的比率发生了明显的变化:H1.0和H1.1变异体增加,而H1.2、H1.3、H1.4和H1.5亚型减少。我们假设,组蛋白H1变体对染色质的不同物理区域进行不同的调节。我们进一步推测,核心组蛋白(H_2A、H_2B、H_3和H_4)与连接物组蛋白H_1的比率可能是控制整体染色质包装的重要参数。我提出了两个目的来检验这一假设。首先,我将使用自上而下和自下而上的质谱分析来确定H1亚型的心脏特异性化学计量学。我将研究核心和连接子组蛋白变体,以揭示与心脏病表型相对应的化学计量学的变化。其次,我将确定含有心脏H1亚型的核小体的基因组位置,并确定疾病发展过程中占据模式的变化。含有核小体的H1变异体将通过免疫沉淀从细胞核中选择,并将通过微阵列/DNA测序确定定位。这些研究将首次深入了解组蛋白H1家族成员在心肌肥厚中的作用,并将为全基因组范围内询问它们在体内的作用奠定基础。
英文摘要
DESCRIPTION (provided by applicant): The adult heart is a dynamic organ; however cardiomyocytes become terminally differentiated shortly after birth. Over time, adult cardiomyocytes are exposed to multiple pathological stressors that can induce hypertrophic growth and dysfunction. The progression of disease leads to a variety of adaptive responses including the re-expression of fetal proteins. Despite advances in the knowledge of pathways that control hypertrophy, little is known about how modifiers of gene regulation influence anatomical reprogramming of the heart. I hypothesize that histone variants are important regulators that govern changes in gene expression in the diseased and failing heart. To study the changes in chromatin-bound proteins that occur as cardiac disease develops, cardiac hypertrophy was induced in mice by constricting the transverse aorta. Our lab's proteomic analyses identified 1048 proteins from cardiac nuclei including 54 histone variants and revealed distinct alterations in nucleosome stoichiometry which correlate with the manifestation of heart disease at the organ level. Moreover, analysis of individual histone H1 variants-the so-called 'linker histone', responsible for the formation of higher order chromatin structures-revealed distinct alterations of the ratios expressed during cardiac hypertrophy: H1.0 and H1.1 variants increased concomitant with a decrease in the H1.2, H1.3, H1.4 and H1.5 isoforms. We hypothesize that histone H1 variants differentially regulate physically distinct regions of chromatin. We further reason that the ratio of core histones (H2a, H2b, H3 and H4) to linker histone H1 may be an important parameter controlling global chromatin packaging. I propose two aims to test this hypothesis. First, I will determine the cardiac-specific stoichiometry of H1 isoforms using top-down and bottom-up mass spectrometry analyses. I will examine core and linker histone variants to reveal changes in stoichiometry corresponding to the phenotypic presentation of heart disease. Second, I will identify the genomic location of nucleosomes containing cardiac H1 isoforms and determine changes in the occupancy pattern during the development of disease. The H1 variant containing nucleosomes will be selected from nuclei by immunoprecipitation and positioning will be determined by microarrays/DNA sequencing. These studies will provide the first insights into the role of the histone H1 family members in cardiac hypertrophy and will lay the groundwork for a genome-wide interrogation of their in vivo actions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of Linker Histone H1 Variants in Cardiac Phenotype in Health and Disease
海外基金